ClinConnect ClinConnect Logo
Search / Trial NCT03497546

Exercise Following Bariatric Surgery for Severe/Morbid Obesity (EFIBAR)

Launched by UNIVERSIDAD DE ALMERIA · Apr 10, 2018

Trial Information

Current as of May 23, 2025

Completed

Keywords

Morbid Obesity Exercise Weight Loss Cardiometabolic Risk Bariatric Surgery

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * To comply with local bariatric surgery criteria:
  • 1. Patients with BMI ≥ 40 kg/m2 (or 35 kg/m2 with comorbidities).
  • 2. Acceptable surgical risk (defined by the approval of anesthetist).
  • 3. Obesity maintained for over 5 years.
  • 4. Failure of previous treatments.
  • 5. To sign informed consent for surgical treatment.
  • Not to present contraindications for supervised physical exercise.
  • To reside in the city of Almeria (Spain) or willingness/predisposition to attend the training sessions 3 times a week during 16 weeks
  • Exclusion Criteria:
  • Severe psychiatric or neurological disorders such as schizophrenia, epilepsia, Alzheimer, Parkinson, personality disorders, eating behaviour disorders, untreated depression or suicidal tendencies.
  • Adrenal or thyroid pathology that might cause obesity.
  • Uncontrolled addiction to alcohol or drugs.

About Universidad De Almeria

The Universidad de Almería is a prominent academic institution in Spain, dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research endeavors aimed at improving patient care and outcomes. With a commitment to ethical standards and rigorous scientific methodology, the Universidad de Almería collaborates with healthcare professionals and researchers to conduct clinical trials that contribute to the development of new therapeutic interventions and enhance the understanding of various medical conditions.

Locations

Almería, , Spain

Patients applied

0 patients applied

Trial Officials

Enrique G Artero, Ph.D.

Principal Investigator

Universidad de Almeria

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials